Y-mAbs Therapeutics, Inc. Total Assets
Y-mAbs Therapeutics, Inc. had Total Assets of $117.21 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-08-08
- 2025-06-30: Assets $117.21M.
- 2025-03-31: Assets $112.61M.
- 2024-12-31: Assets $119.90M.
- 2024-09-30: Assets $120.92M.
| Period end | Assets |
|---|---|
| 2025-06-30 | $117.21M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $112.61M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $119.90M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $120.92M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $144.03M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $123.31M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $127.87M 10-K · filed 2025-03-04 |
| 2023-09-30 | $128.88M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $132.40M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $137.44M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $141.46M 10-K · filed 2024-02-29 |
| 2022-09-30 | $143.91M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $165.18M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $191.05M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $212.78M 10-K · filed 2023-03-30 |
| 2021-09-30 | $239.98M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $259.48M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $274.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $132.05M 10-K · filed 2022-03-01 |
| 2020-09-30 | $143.19M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $167.33M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $194.07M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $216.37M 10-K · filed 2021-03-01 |
| 2019-09-30 | $103.68M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $126.04M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $140.00M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $151.92M 10-K · filed 2020-03-12 |
| 2018-09-30 | $166.39M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $92.13M 10-K · filed 2019-03-22 |